C M Bidwell & Associates LTD Biogen Inc. Transaction History

C M Bidwell & Associates LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $115,054 - $132,949	-418 Reduced 54.57%	348 $99,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $10,262 - $11,693	-40 Reduced 4.96%	766 $212,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $156,920 - $216,378	806 New	806 $215,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $97,964 - $113,112	-370 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $99,584 - $131,881	-385 Reduced 50.99%	370 $99,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $266,968 - $338,652	-993 Reduced 56.81%	755 $239,000
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $10,122 - $13,987	-46 Reduced 2.56%	1,748 $519,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $390,087 - $437,520	1,794 New	1,794 $418,000
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $260,955 - $287,646	-1,190 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $257,884 - $403,362	1,190 New	1,190 $281,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.